Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Why a Threshold Case Volume in Complex Systems Such as Thrombectomy in Stroke Care Is Inadequate to Discriminate Quality Outcomes
- Hospital transfer associated with increased mortality after endovascular revascularization for acute ischemic stroke
- Transfer to High-Volume Centers Associated With Reduced Mortality After Endovascular Treatment of Acute Stroke
- Red pill, blue pill: reflections on the emerging large vessel stroke 'market'
- Regional Availability of Mechanical Embolectomy for Acute Ischemic Stroke in California, 2009 to 2010
- Geographic Access to Acute Stroke Care in the United States
- Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy
- Future directions in IAT: better studies, better selection, better timing and better techniques
- Don't Hurt My Brain ... It's My Second Favorite Organ
- The endovascular journey
- Demand-supply of neurointerventionalists for endovascular ischemic stroke therapy
- Who should treat stroke?
- Acute Stroke Treatment: Carotid "Stenters" to the Rescue
- Stroke Intervention: Catheter-Based Therapy for Acute Ischemic Stroke
- Meta-analysis of randomized intra-arterial thrombolytic trials for the treatment of acute stroke due to middle cerebral artery occlusion
- Microcatheter contrast injections during intra-arterial thrombolysis increase intracranial hemorrhage risk
- The yes/no song of stroke case volume and manpower needs
- Recommendations for the Implementation of Telemedicine Within Stroke Systems of Care: A Policy Statement From the American Heart Association
- A Call to Arms...Legs, Brains, and Kidneys!
- Intra-Arterial Stroke Therapy: An Assessment of Demand and Available Work Force
- Microcatheter Contrast Injections During Intra-Arterial Thrombolysis May Increase Intracranial Hemorrhage Risk